When did 10x Genomics, Inc. report Q4 2024 earnings?

10x Genomics, Inc. (TXG) reported Q4 2024 earnings on February 12, 2025 after market close.

What were 10x Genomics, Inc.'s Q4 2024 revenue and EPS?

10x Genomics, Inc. reported revenue of $165.0M and eps of $-0.40 for Q4 2024.

Did 10x Genomics, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $165.0M by $40.7K. EPS missed the consensus estimate of $-0.29 by $0.11.

Where can I find 10x Genomics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001770787-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.

10x Genomics, Inc. TXG Q4 2024 Annual earnings

Reported February 12, 2025 · After market close

Revenue$165.0MIn line

EPS-$0.40Miss by $0.11

Revenue estimate$165.0M

EPS estimate-$0.29

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$146.7M

EPS estimate-$0.23

Financials

Q4 2024

Income statement

See full

Revenue$165.0M-10.3%

Gross profit$111.0M-4.2%

Operating income-$49.8M+9.7%

Net income-$49.0M-0.2%

EPS (diluted)-$0.410.0%

Balance sheet

See full

Cash & equivalents$344.1M-4.2%

Total debt$82.6M-13.4%

Total equity$710.1M-4.2%

Total assets$918.6M-4.8%

Cash flow

See full

CapEx$2.7M-21.3%

Free cash flow-$9.5M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.74B-73.8%

Enterprise value$1.48B-76.8%

P/S2.8×-7.9×

Profitability

See full

Gross margin67.9%+1.7pp

Operating margin-31.9%-6.5pp

Net margin-29.9%-6.4pp

Returns & leverage

See full

Return on equity-25.2%-4.8pp

Debt / equity0.1×0.0×

Current ratio5×+0.3×

Segments

By geography

See full

Europe, Middle East and Africa$49.8M-1.5%

Asia-Pacific (excluding China)$13.4M-24.9%

Americas (excluding United States)$2.9M-35.0%

By product

See full

Chromium$97.7M-17.3%

Spatial$13.4M-50.7%

Services$7.0M+33.4%

Versus estimates

Revenue

Q1 2026$150.8MBeat by $4.4M Q4 2025$166.0MBeat by $6.4M Q3 2025$149.0MBeat by $6.5M Q2 2025$172.9MBeat by $33.4M Q1 2025$154.9MBeat by $9.6M

Q4 2024$165.0MIn line

Diluted EPS

Q1 2026-$0.10Beat by $0.19 Q4 2025-$0.13Beat by $0.06 Q3 2025-$0.22Miss by $0.15 Q2 2025$0.28Beat by $0.63 Q1 2025-$0.36Beat by $0.09

Q4 2024-$0.40Miss by $0.11

Ask the moment 10x Genomics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did 10x Genomics, Inc. report Q4 2024 earnings?: 10x Genomics, Inc. (TXG) reported Q4 2024 earnings on February 12, 2025 after market close.
What were 10x Genomics, Inc.'s Q4 2024 revenue and EPS?: 10x Genomics, Inc. reported revenue of $165.0M and eps of $-0.40 for Q4 2024.
Did 10x Genomics, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $165.0M by $40.7K. EPS missed the consensus estimate of $-0.29 by $0.11.
Where can I find 10x Genomics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001770787-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.